Magenta Therapeutics, Inc.
MGTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56 | $13 | $10 | $23 |
| Short-Term Investments | $347 | $244 | $253 | $252 |
| Receivables | $5 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $6 | $7 | $6 |
| Total Curr. Assets | $414 | $264 | $271 | $281 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $153 | $52 | $68 | $82 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $9 | $8 | $10 |
| Total NC Assets | $164 | $62 | $78 | $93 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $577 | $326 | $349 | $374 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $8 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $14 | $8 | $13 |
| Total Curr. Liab. | $24 | $20 | $17 | $18 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $2 | $2 | $2 |
| Total NC Liab. | $7 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $31 | $23 | $20 | $22 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$272 | -$236 | -$204 | -$174 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $819 | $538 | $532 | $527 |
| Total Equity | $546 | $303 | $329 | $352 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $577 | $326 | $349 | $374 |
| Net Debt | -$55 | -$12 | -$9 | -$21 |